BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9645916)

  • 21. [EXPERIENCES WITH PARTIAL THROMBOPLASTIN TIME TEST].
    UKITA M; NISHI A; FUJIMAKI M
    Rinsho Byori; 1964 Feb; 12():170-2. PubMed ID: 14172307
    [No Abstract]   [Full Text] [Related]  

  • 22. Assays for lupus anticoagulant: the sensitivity of different assays.
    Jain A; Dash S; Marwaha N; Deodhar SD; Sehgal S
    Med Lab Sci; 1991 Jan; 48(1):31-5. PubMed ID: 1905773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clotting changes in borderline hypertension.
    Patrassi GM; Fallo F; Santarossa A; Sartori MT; Casonato A; Girolami A
    J Hum Hypertens; 1987 Sep; 1(2):101-3. PubMed ID: 3506621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clotting, activated partial thromboplastin and coagulation times in monitoring heparin therapy.
    Kurec AS; Morris MW; Davey FR
    Ann Clin Lab Sci; 1979; 9(6):494-500. PubMed ID: 518012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the KC10 semi-automatic modular clot detection device].
    Crespo B; Ankri A; Lesty C
    Nouv Rev Fr Hematol (1978); 1983; 25(2):113-21. PubMed ID: 6408609
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of lupus-like anticoagulants by an enzyme-linked immunosorbent assay using a partial thromboplastin as antigen; a comparative study.
    Arnout J; Huybrechts E; Vanrusselt M; Falcon C; Vermylen J
    Thromb Haemost; 1990 Aug; 64(1):26-31. PubMed ID: 2125756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interpretation of screening tests of hemostasis].
    Wuillemin WA; Heizmann M
    Praxis (Bern 1994); 2003 Jan; 92(3):57-64. PubMed ID: 12577721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of the protein induced by vitamin K absence on thrombotest and hepaplastintest in the patients treated with oral anticoagulant].
    Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
    Rinsho Byori; 1983 Jan; 31(1):105-9. PubMed ID: 6865023
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of preeclampsia on maternal and cord blood clotting activity.
    Lox CD; Word RA; Corrigan JJ
    Am J Perinatol; 1985 Oct; 2(4):279-82. PubMed ID: 4052178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A new system of analysis for partial thromboplastin time. Comparison with other blood coagulation tests in liver diseases].
    Pagliano FM; Slucca P; Cestari G
    Arch Sci Med (Torino); 1976; 133(4):321-5. PubMed ID: 1023840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants: Limitations and Solutions.
    Ebner M; Birschmann I; Peter A; Härtig F; Spencer C; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
    Stroke; 2017 Sep; 48(9):2457-2463. PubMed ID: 28775134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of two simple tests for the lupus anticoagulant.
    Exner T
    Am J Clin Pathol; 1985 Feb; 83(2):215-8. PubMed ID: 3918436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant.
    Forastiero RR; Falcón CR; Carreras LO
    Haemostasis; 1990; 20(4):208-14. PubMed ID: 2122955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinical evaluation of automated chromogenic tests as substitutes for conventional prothrombin time and activated partial thromboplastin time tests.
    Duncan A; Bowie EJ; Owen CA; Fass DN
    Clin Chem; 1985 Jun; 31(6):853-5. PubMed ID: 3995763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Abnormality of blood coagulation in idiopathic thrombocytopenic purpura (ITP)].
    Wada H; Deguchi A; Mori Y; Ohkubo I; Tsuda M; Nagano T; Tsuzi K; Yamaguchi T; Minami N; Deguchi K
    Rinsho Ketsueki; 1987 Mar; 28(3):338-44. PubMed ID: 3112443
    [No Abstract]   [Full Text] [Related]  

  • 36. Differing opinions on value of PIVKA test.
    Giger U
    J Am Vet Med Assoc; 2003 Apr; 222(8):1070; author reply 1070-1. PubMed ID: 12710764
    [No Abstract]   [Full Text] [Related]  

  • 37. Laboratory support in the diagnosis of coagulation disorders.
    Giddings JC; Peake IR
    Clin Haematol; 1985 Jun; 14(2):571-95. PubMed ID: 3899445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple coagulation factor abnormalities in commercially available Passovoy-deficient plasma.
    Foster PA; Montgomery RR; Endres-Brooks J
    Blood; 1992 Dec; 80(12):3260-1. PubMed ID: 1467533
    [No Abstract]   [Full Text] [Related]  

  • 39. [Activity and concentration determinations of coagulation factors in conventional and virus-inactivated coagulation-active plasma].
    Lutze G; Hartung KJ
    Beitr Infusionsther Transfusionsmed; 1994; 32():415-8. PubMed ID: 9480135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological and analytical variations of 16 parameters related to coagulation screening tests and the activity of coagulation factors.
    Chen Q; Shou W; Wu W; Guo Y; Zhang Y; Huang C; Cui W
    Semin Thromb Hemost; 2015 Apr; 41(3):336-41. PubMed ID: 25839868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.